BNTX

#494
BioNTech SE - American Depositary Shares
95.9 5 USD
+2.10%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
95.95
95.95
Faixa anual
79.52
123.98
Mudança diária
+2.10%
Mudança mensal
-6.21%
Mudança em 6 meses
-5.00%
Mudança anual
-0.47%
Fechamento anterior
93.9 8
Open
95.9 5
Mínimo
95.9 5
High
95.9 5
Volume
111
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Notícias